Fifth
Annual Grant Winners 2004-2005
Ling Li, Ph.D., HPD – College
of Dental Medicine
Xudong Yuan, Ph.D., HPD – College of
Pharmacy
Dean Robert Uchin, HPD – College of Dental
Medicine
Dean William Hardigan, HPD – College
of Pharmacy
Title: Targeted
Gene Silencing by Small RNA Interference:
Development of a Novel Delivery Method
Abstract:
One of key aspect of gene therapy is able to targeted
reduce or silence the expression of deleterious genes,
such as cancer or pain causing genes. RNA interference
(RNAi) induced by small interfering RNA (siRNA) can lead
to highly specific and extraordinarily efficient degradation
of the corresponding mRNA, thus suppressing the targeted
gene expression. However, advances in the areas of delivery,
systemic spreading and duration of the silencing are
necessary before the technology can enter clinical phase.
The common used methods for delivery of siRNA are liposome
and viral vector systems. The liposome deliver system is
powerful in some cell lines. However, in most cell lines
and mammalian tissues, the delivery efficiency is low and
the duration of the silencing effect is short, lasting ~3
days. The pantropic retroviral vector can delivery siRNA
into most of cell lines and mammalian tissues. However, the
reverse transcription of the retroviral vector has introduced
mutations into siRNA, attenuating the silencing effect. Recently,
biocompatible and biodegradable polymeric microparticles
and nanoparticles have been studied for the delivery
of drugs to obtain enhanced therapeutic efficacy, prolonged
half-life and reduced systemic side effect [For reviews,
see (Cui and Mumper, 2003; Emerich and Thanos, 2003;
Panyam and Labhasetwar, 2003; Vijayanathan et al., 2002)].
Therefore, we hypothesize that the new delivery system, nanoparticulate
drug delivery system may be an efficient method to deliver
siRNA , achieving high efficiency and long duration of silencing
effect. Using Green Fluorescent Protein and its known efficient
siRNA as a model system, we will compare the efficiency and
duration of our new delivery system with the conventional
liposome and retroviral delivery system. The efficiency and
duration of the silencing effect will be determined by the
inhibition of the green fluorescent protein expression using
a fluorescent microscope equipped with a digital imaging
system. The completion of this study will contribute to the
long-term goal of developing targeted gene therapy system.